Cardiology
Conference Coverage
It’s been a good year for heart failure research ... mostly
WASHINGTON – The highs ... and the lows.
Conference Coverage
Coverage denials plague U.S. PCSK9-inhibitor prescriptions
WASHINGTON – A prescription for a PCSK9 inhibitor isn’t likely to be covered.
Conference Coverage
Death watch intensifies for HDL-based interventions
WASHINGTON – The study of HDL cholesterol–based interventions to treat atherosclerotic disease “is on life support.”
Conference Coverage
Michigan model embeds pharmacists into primary care
Incorporating pharmacists into primary care offices can significantly impact patient care and save health care costs.
Conference Coverage
Caution urged in extending dual antiplatelet therapy
Think carefully before extending DAPT beyond 6 months in drug-eluting stent recipients with stable ischemic heart disease.
Conference Coverage
Coronary flow reserve reveals hidden cardiovascular risk
SNOWMASS, COLO. – Noninvasive tool sheds new light on excess cardiovascular risk in women.
Conference Coverage
Is there clinical benefit to activity trackers?
SAN DIEGO – Wearable activity trackers may help improve patients’ physical fitness, but alone they do not promote physical activity or improve...
From the Journals
Weight fluctuations linked to higher mortality, CV events
Weight fluctuations – like the typical pattern of weight loss followed by partial or total regain that affects most people attempting to lose...
From the Journals
Cell sheet transplantation improves ischemic cardiomyopathy at 1 year
Affixing a sheet of autologous stem cells directly onto the left ventricle led to improvements in ICM out to 1 year.
Commentary
Stroke hospitals owe all patients rapid thrombolysis
A high level of thrombolysis treatment is possible. It just isn’t being done everywhere.
Conference Coverage
Uptake of new heart failure drugs slow despite guidelines
Ivabradine and sacubitril/valsartan reduce mortality and hospitalizations.